Connection

Pål Aukrust to Acute Coronary Syndrome

This is a "connection" page, showing publications Pål Aukrust has written about Acute Coronary Syndrome.
Connection Strength

0.385
  1. Homeostatic Chemokines and Prognosis in Patients With Acute Coronary Syndromes. J Am Coll Cardiol. 2019 08 13; 74(6):774-782.
    View in: PubMed
    Score: 0.074
  2. Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial. Eur Heart J Acute Cardiovasc Care. 2020 Jun; 9(4):313-322.
    View in: PubMed
    Score: 0.073
  3. Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes. Arterioscler Thromb Vasc Biol. 2019 02; 39(2):294-302.
    View in: PubMed
    Score: 0.071
  4. Serum neutrophil gelatinase-associated lipocalin (NGAL) concentration is independently associated with mortality in patients with acute coronary syndrome. Int J Cardiol. 2018 07 01; 262:79-84.
    View in: PubMed
    Score: 0.067
  5. Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial. J Am Heart Assoc. 2018 01 12; 7(2).
    View in: PubMed
    Score: 0.066
  6. Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes. J Am Coll Cardiol. 2008 Feb 12; 51(6):627-33.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.